USD 29.55
(-4.4%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 171.73 Million | -1.25 Million | 29.91 Million | 41.43 Million | 93.75 Million | 110.1 Million |
Net Income | -29.7 Million | 15.03 Million | 80.59 Million | -112.7 Million | 14.82 Million | 29.56 Million |
Depreciation & Amortization | 10.5 Million | 7.67 Million | 6.57 Million | 6.65 Million | 11.19 Million | 5.17 Million |
Deferred income taxes | -8.3 Million | -3.93 Million | 5.63 Million | -17.46 Million | 10.14 Million | -16.22 Million |
Stock-based compensation | 3.24 Million | 2.82 Million | 3.44 Million | 4.99 Million | 6.15 Million | 5.24 Million |
Change in working capital | 74.36 Million | -77.19 Million | -70.94 Million | 29.27 Million | 94.43 Million | 65.68 Million |
Other non-cash items | 121.62 Million | 54.34 Million | 4.62 Million | 130.68 Million | -42.99 Million | 20.65 Million |
Investing Cash Flow | -149.88 Million | -19.17 Million | 31.73 Million | -92.87 Million | 4.5 Million | -19.2 Million |
Investments in PPE | -10.88 Million | -2.13 Million | -13.97 Million | -18.86 Million | -32.42 Million | -33.05 Million |
Acquisitions | 10.88 Million | - | -45.7 Million | - | - | 276.05 Million |
Investment purchases | -292.94 Million | -297.34 Million | -405.43 Million | -444.66 Million | -257.81 Million | -540.35 Million |
Sales/Maturities of investments | 162.08 Million | 280.41 Million | 451.13 Million | 376.21 Million | 311.67 Million | 263.8 Million |
Other Investing Activities | -19.02 Million | -103 Thousand | 45.7 Million | -5.56 Million | -16.93 Million | 290.39 Million |
Financing Cash Flow | -16.45 Million | -15.03 Million | -17.49 Million | 18.66 Million | -41.98 Million | -115.18 Million |
Debt repayment | - | - | - | -71 Thousand | -9.32 Million | - |
Dividends payments | -16.16 Million | -15.86 Million | -15.06 Million | -28.52 Million | -32.66 Million | -105.4 Million |
Common Stock Repurchased | -290 Thousand | - | -2.42 Million | -2.81 Million | -11.7 Million | -5.4 Million |
Common Stock Issuance | -290 Thousand | 828 Thousand | -421 Thousand | -71 Thousand | 2.37 Million | 7.17 Million |
Other Financing Activities | -290 Thousand | 828 Thousand | -421 Thousand | 50.14 Million | 9.32 Million | -11.54 Million |
Accounts receivables | -151.37 Million | -92.09 Million | 33.24 Million | -47.83 Million | -21.83 Million | -16.45 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 225.74 Million | 14.9 Million | -104.19 Million | 77.1 Million | 116.27 Million | 82.14 Million |
Cash at beginning of period | 96.65 Million | 132.1 Million | 87.94 Million | 120.72 Million | 64.45 Million | 95.56 Million |
Cash at end of period | 102.04 Million | 96.65 Million | 132.1 Million | 87.94 Million | 120.72 Million | 64.45 Million |
Capital Expenditure | -10.88 Million | -2.13 Million | -13.97 Million | -18.86 Million | -32.42 Million | -33.05 Million |
Effect of forex changes on cash | - | - | - | - | - | -6.82 Million |
Net cash flow / Change in cash | 5.39 Million | -35.45 Million | 44.15 Million | -32.77 Million | 56.26 Million | -31.1 Million |
Free Cash Flow | 160.85 Million | -3.38 Million | 15.94 Million | 22.57 Million | 61.32 Million | 77.05 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.73 Million | 13.5 Million | 19.6 Million | -29.7 Million | 6.38 Million | -56.38 Million |
Depreciation & Amortization | 3.14 Million | 2.67 Million | 2.66 Million | 10.5 Million | 2.65 Million | 2.53 Million |
Deferred income taxes | -2.55 Million | -7.17 Million | 3.32 Million | -8.3 Million | -5.2 Million | -4.25 Million |
Stock-based compensation | 1.55 Million | 1.15 Million | 122 Thousand | 3.24 Million | 949 Thousand | 1.09 Million |
Change in working capital | 89.14 Million | -33.33 Million | -1.41 Million | 74.36 Million | 26.5 Million | 70.17 Million |
Other non-cash items | 8.06 Million | 22.65 Million | -2.07 Million | 121.62 Million | 80.34 Million | 31.47 Million |
Investing Cash Flow | -218.48 Million | 83.88 Million | 14.77 Million | -149.88 Million | -118.14 Million | -14.01 Million |
Investments in PPE | -3.23 Million | -2.6 Million | -2.84 Million | -10.88 Million | -2.42 Million | -3 Million |
Acquisitions | - | - | -118.73 Million | 10.88 Million | 115.72 Million | 3 Million |
Investment purchases | -394.63 Million | -41.35 Million | -45.83 Million | -292.94 Million | -140.4 Million | -45.69 Million |
Sales/Maturities of investments | 179.38 Million | 127.83 Million | 63.45 Million | 162.08 Million | 24.67 Million | 42.69 Million |
Other Investing Activities | -215.24 Million | 86.48 Million | 118.73 Million | -19.02 Million | -115.72 Million | -11.01 Million |
Financing Cash Flow | 62.79 Million | -4.3 Million | -4.1 Million | -16.45 Million | -4.04 Million | -4.16 Million |
Debt repayment | -66.96 Million | - | -25.99 Thousand | - | - | - |
Dividends payments | -4.05 Million | -4.04 Million | -4.04 Million | -16.16 Million | -4.04 Million | -4.04 Million |
Common Stock Repurchased | -114 Thousand | -256 Thousand | -67 Thousand | -290 Thousand | -5000.00 | -122 Thousand |
Common Stock Issuance | - | -256 Thousand | -290 Thousand | -290 Thousand | - | 96 Thousand |
Other Financing Activities | 66.85 Million | -256 Thousand | -67 Thousand | -290 Thousand | -5000.00 | -121.99 Thousand |
Accounts receivables | -70.29 Million | -70.15 Million | -783 Thousand | -151.37 Million | -28.72 Million | -97.73 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 1.16 Million | 1.2 Million | -632 Thousand | 225.74 Million | 55.23 Million | 167.9 Million |
Cash at beginning of period | 217.78 Million | 102.04 Million | 69.15 Million | 96.65 Million | 79.7 Million | 53.23 Million |
Cash at end of period | 153.43 Million | 217.78 Million | 102.04 Million | 102.04 Million | 69.15 Million | 79.7 Million |
Capital Expenditure | -3.23 Million | -2.6 Million | -2.84 Million | -10.88 Million | -2.42 Million | -3 Million |
Effect of forex changes on cash | - | - | 6.88 Million | - | - | - |
Net cash flow / Change in cash | -64.35 Million | 115.73 Million | 32.89 Million | 5.39 Million | -10.55 Million | 26.47 Million |
Free Cash Flow | 88.09 Million | 33.55 Million | 19.38 Million | 160.85 Million | 109.22 Million | 41.64 Million |
TRMED
UCOBANK
4513
8182
4510
1541